Carter Bankshares, Inc.
NASDAQ:CAREBanks - Regional
-$0.20 today
- Market cap
- $635.59M
- Beta
- 0.55
- P/E (TTM)
- 6.2
- EPS (TTM)
- $4.95
- Dividend yield
- 0.33%
Volume 0.19M
Average 0.32M
CARE Sales of Investments
Cash received from selling or redeeming investments.
Carter Bankshares, Inc.NASDAQ: CARE
Sales of Investments · Q1 FY2026 · quarter ended Mar 2026
Sales of investments growth accelerates
Q1 FY2026 sales of investments of $31.46M rose 94.2% year over year, ahead of the +51.8% change in trailing-twelve-month sales of investments. Sequentially, it fell 31.2% from the prior quarter. Over 3 fiscal years it compounded at +3.5% a year.
Context
- Sales of investments amounted to 45.5% of revenue in FY2025, up 11.6 pp from a year earlier.
- Sales of investments increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +94.2% holds above the trailing-twelve-month pace of +51.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Sales of Investments history
USD · from the cash flow
- Latest · FY2025
- 115.93M USD
- Year-over-year change
- +42.4%
- 4-year CAGR
- -21.6%
| Period | Period end | Sales of Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 115.93M | +42.4% |
| FY2024 | 2024-12-31 | 81.41M | -11.7% |
| FY2023 | 2023-12-31 | 92.22M | -11.7% |
| FY2022 | 2022-12-31 | 104.47M | -66.0% |
| FY2021 | 2021-12-31 | 307.25M | — |
Sales of Investments vs competitors
How CARE compares with its peers on the latest reported figures
- CARE's LTM Mar 2026 sales of investments of $131.19M is the 4th largest of the 11 companies compared; the peer median is $52.86M.
- Its year-over-year change of +51.8% is the 5th highest of 11, against a peer median of +26.7%.
- Sales of investments amounts to 41.0% of revenue for CARE, versus a peer median of 30.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $413.17M | +14.1% | +5.8% | 67.0% | |
| LTM Mar 2026 | $379.23M | +106.1% | +74.5% | 216.5% | |
| LTM Mar 2026 | $134.34M | +58.1% | +21.0% | 55.3% | |
| LTM Mar 2026 | $131.19M | +51.8% | +3.5% | 41.0% | |
| LTM Mar 2026 | $63.03M | -21.7% | +5.9% | 33.4% | |
| LTM Mar 2026 | $57.32M | +127.1% | +50.4% | 27.1% | |
| LTM Mar 2026 | $48.41M | +241.2% | -2.5% | 23.5% | |
| LTM Mar 2026 | $43.18M | +18.7% | +13.9% | 50.2% | |
| LTM Mar 2026 | $39.19M | +34.6% | -2.6% | 27.2% | |
| LTM Mar 2026 | $28.86M | -35.7% | +12.2% | 11.6% | |
| LTM Mar 2026 | $15.74M | -1.9% | -24.2% | 12.8% | |
| Peer median (excluding CARE) | $52.86M | +26.7% | +9.0% | 30.3% | |
Competitors are the stored peer set for CARE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 31.59M | 50.12M | 23.38M | 24.52M | 31.36M |
| Depreciation & Amortization | 6.23M | 6.06M | 6.25M | 7.06M | 7.86M |
| Deferred Income Tax | 4.82M | 4.25M | 2.47M | 3.21M | 2.82M |
| Stock-Based Compensation | 1.04M | 1.31M | 1.56M | 1.75M | 2.07M |
| Change in Working Capital | 5.61M | (722K) | (1.43M) | 1.83M | (1.98M) |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | 5.61M | (722K) | (1.43M) | 1.83M | (1.98M) |
| Other Non-Cash Items | 28.25M | 9.77M | 14.5M | (1.43M) | (2.27M) |
| Operating Cash Flow | 77.54M | 70.79M | 46.73M | 36.94M | 39.86M |
| Capital Expenditures | (8.48M) | (5.89M) | (9.8M) | (8.13M) | (8.06M) |
| Acquisitions (Net) | (73.92M) | 0 | 0 | 0 | 53.57M |
| Purchases of Investments | (466.65M) | (135.63M) | (24.94M) | (25.13M) | (63.68M) |
| Sales of Investments | 307.25M | 104.47M | 92.22M | 81.41M | 115.93M |
| Other Investing Activities | 135.45M | (345.02M) | (364.5M) | (116.55M) | (253.68M) |
| Investing Cash Flow | (106.36M) | (382.07M) | (307.01M) | (68.4M) | (155.91M) |
| Debt Repayment | (28M) | 173.55M | 194.98M | (323.4M) | 108.5M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (157K) | (42.93M) | (16.42M) | 0 | (20M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 92.83M | (50.27M) | 89.38M | 431.51M | 1.54M |
| Financing Cash Flow | 64.67M | 80.35M | 267.94M | 108.11M | 90.04M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 35.86M | (230.93M) | 7.66M | 76.64M | (26.01M) |
| Free Cash Flow | 69.05M | 64.9M | 36.93M | 28.81M | 31.81M |
Carter Bankshares, Inc.
NASDAQ:CARE
Intrinsic Alpha fair value
Locked
Current Price
$28.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.